Finance

Lists
ALA:ASX
Arovella Therapeutics Ltd
A$0.054
+1.89%
(+0.0010) 1D
Sep 25, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for ALA...
Open
A$0.05
High
A$0.05
Low
A$0.05
Mkt. cap
69.19M
Avg. vol.
626.57K
Volume
1.09M
52-wk high
A$0.12
52-wk low
A$0.05
EPS
-A$0.01
Shares outstanding
1.21B
No. of employees
14
Open
A$0.05
High
A$0.05
Low
A$0.05
Mkt. cap
69.19M
Avg. vol.
626.57K
Volume
1.09M
52-wk high
A$0.12
52-wk low
A$0.05
EPS
-A$0.01
Shares outstanding
1.21B
No. of employees
14
About Arovella Therapeutics Ltd
CEOMichael Baker
Employees14
Founded1999
Headquarters-
SectorPharmaceutical industry
Websitearovella.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.60M
1.60M
144.61K
144.61K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.37M
1.37M
1.57M
1.57M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
721.91K
721.91K
670.81K
670.81K
Operating expense
2.75M
2.75M
2.86M
2.86M
Total operating expenses
2.75M
2.75M
2.86M
2.86M
Operating income
-1.15M
-1.15M
-2.71M
-2.71M
Other non operating income
-
-
-
-
EBT including unusual items
-939.35K
-939.35K
-2.52M
-2.52M
EBT excluding unusual items
-939.35K
-939.35K
-2.52M
-2.52M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
449.58K
449.58K
528.34K
528.34K
Net income
-939.35K
-939.35K
-2.52M
-2.52M
Net profit margin
-58.55%
-58.55%
-1,741.81%
-1,741.81%
Earnings per share
-
-
-
-
Interest and investment income
207.81K
207.81K
192.21K
192.21K
Interest expense
-
-
-
-
Net interest expenses
207.81K
207.81K
192.21K
192.21K
Depreciation and amortization charges
29.58K
29.58K
29.28K
29.28K
EBITDA
-1.12M
-1.12M
-2.68M
-2.68M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps